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Abstract
Background: The consumption of berry fruits, including strawberries, has been suggested to have beneficial effects against
oxidative stress mediated diseases. Berries contain multiple phenolic compounds and secondary metabolites that
contribute to their biological properties.
Methodology/Principal Findings: Current study investigates the anticancer activity of the methanolic extract of strawberry
(MESB) fruits in leukaemia (CEM) and breast cancer (T47D) cell lines ex vivo, and its cancer therapeutic and chemopreventive
potential in mice models. Results of MTT, trypan blue and LDH assays suggested that MESB can induce cytotoxicity in cancer
cells, irrespective of origin, in a concentration- and time-dependent manner. Treatment of mice bearing breast
adenocarcinoma with MESB blocked the proliferation of tumor cells in a time-dependent manner and resulted in extended
life span. Histological and immunohistochemical studies suggest that MESB treatment affected tumor cell proliferation by
activating apoptosis and did not result in any side effects. Finally, we show that MESB can induce intrinsic pathway of
apoptosis by activating p73 in breast cancer cells, when tumor suppressor gene p53 is mutated.
Conclusions/Significance: The present study reveals that strawberry fruits possess both cancer preventive and therapeutic
values and we discuss the mechanism by which it is achieved.
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Introduction
A diet rich in fruits and vegetables has been associated with
a reduced risk of diseases, such as cardiovascular disorders and
cancer [1,2,3,4]. Previously, an efficient food based approach for
cancer prevention was studied in a rodent model of colon
carcinoma [5]. It has been shown that the phytochemicals present
in fruits and vegetables are more effective than their individual
constituents in preventing cancer through both additive and
synergetic effects [6,7]. Hence, it is important to study the
potential activity of fruits and vegetables using whole extracts
containing various phytochemicals, instead of using purified
molecules or fractions enriched with certain classes of molecules.
Previous studies suggest that consumption of berry fruits can
have beneficial effects against diseases such as cancer [8]. Berries
contain multiple phenolic compounds, which contribute to their
biological properties. It has been suggested that bioactive
components of berry invoke anti-cancer effects through various
complementary and overlapping mechanisms of action including
the induction of metabolizing enzymes, modulation of gene
expression etc. However, their definitive mechanism of action is
largely unknown [9].
Strawberries are a good source of natural antioxidants [10],
which can be linked to the level of phenolic compounds in these
fruits [11]. A recent study showed that strawberry extracts exhibit
a higher level of antioxidant capacity against free radical species
including superoxide radicals, hydrogen peroxide, hydroxyl
radicals, and singlet oxygen [12]. Strawberries contain antiox-
idants, such as vitamin C, hydroxycinnamic acids, anthocyanins
and flavonoids [11,13]. Besides, due to relatively high content of
ellagic acid, an antioxidant that can exert antimutagenic and
anticarcinogenic effect, it has been a preferred target for cancer
studies [14,15]. A study has also shown that strawberries have
potent anti-proliferative activity on human liver cancer cells,
HepG2 [16]. However, there are no studies to investigate its
anticancer potential and the mechanism by which it exerts its
effect.
In most of the cancers, mutation in the tumor suppressor gene,
p53, significantly contributes to cancer development [17]. Hence,
p53 analogues like p73, p63 etc. are shown to play a similar
function during oncogenesis [18]. p73 shares significant sequence
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as well as functional homology with p53. The central specific DNA
binding sequence, N-terminal activation and C-terminal oligo-
merization domains share significant sequence homology between
them. Similar to p53, proteins like BAX, PUMA are also direct
targets of p73 [19].
Various phytochemicals and chemically synthesized small
molecules induce apoptosis, largely through the activation of
intrinsic pathway. Intrinsic apoptotic pathway involves a variety of
stimuli from inside the cells like DNA damage, ROS generation
etc. The major players of this pathway include BCL2 family of
proteins, which are mainly classified as proapoptotic and
antiapoptotic proteins, based on their activity. An imbalance in
the ratio between these classes of proteins leads to damage of
mitochondrial membrane integrity resulting in CYTOCHROME
C release and CASPASE 9 followed by CASPASE 3 activation
[20].
In the present study, we show that extracts prepared from
Indian strawberry fruits induce cytotoxicity by activating intrinsic
pathway of apoptosis, through a p53 independent mechanism in
breast cancer cells. MESB also interferes with progression of
tumors in breast cancer mouse models and results in the extended
lifespan without affecting other cellular functions and body weight.
Most importantly, we also provide evidence that strawberry
consumption can delay tumorigenesis in mice.
Materials and Methods
Chemicals and Reagents
All chemicals used in the present study were of analytical grade
and purchased from Sigma-Aldrich (USA) and antibodies were
purchased from Santa Cruz Biotechnology (USA) and Cell
Signalling Technology (USA).
Preparation of Methanolic Extract of Strawberry (MESB)
Indian strawberry fruits were purchased from the local markets,
cut into small pieces and dried in shadow. The powdered
strawberry was then extracted with methanol. Following evapo-
ration, crude methanolic extracts were stored at room temperature
under sterile conditions until further use.
Cell Culture
Human T-cell leukemia cells, CEM and human breast cancer
cells, T47D were purchased from National Centre for Cell
Science, Pune (India). Cells were cultured in RPMI 1640 (Sera
Lab, UK) containing 10% FBS (Gibco BRL, USA), 100 U of
Penicillin G/ml and 100 mg of streptomycin/ml (Sigma-Aldrich,
USA) at 37uC in a humidified atmosphere containing 5% CO2.
Trypan Blue Dye Exclusion Assay
The effect of MESB on cell viability of CEM and T47D cells
was determined by trypan blue dye exclusion assay [21,22]. CEM
and T47D cells were cultured (0.756105 cells/ml) and increasing
concentrations (0.1, 0.2, 0.5 and 1 mg/ml) of MESB was added
and incubated. Cells were collected after 48 and 72 h of
incubation. Number of viable cells was determined by trypan
blue staining. Experiments were repeated three independent times
and the data was presented as bar diagram with error bars.
Figure 1. Assessment of MESB induced cytotoxicity in leukemic (CEM) and breast cancer (T47D) cell lines. CEM and T47D cells were
treated with increasing concentrations of MESB (0.1, 0.2, 0.5 and 1 mg/ml) and cells were harvested after 48 or 72 h of treatment and subjected to
trypan blue, MTT and LDH assays. A. Determination of cell viability by trypan blue assay in CEM cells. B. Evaluation of cell proliferation by MTT assay
in CEM cells. C. Bar diagram showing release of lactate dehydrogenase following MESB treatment in CEM cells. D. Assessment of cell viability using
trypan blue assay in T47D cells. E. Determination of cell proliferation by MTT assay in T47D cells after MESB treatment. F. LDH assay showing release
of lactate dehydrogenase in T47D cells following addition of MESB. In each panel, error bars were calculated based on results obtained from
minimum of three independent experiments. In all panels, *p,0.05, **p,0.005, and ***p,0.0005.
doi:10.1371/journal.pone.0047021.g001
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MTT Assay
The MTT assay was performed as described earlier [22,23].
Both CEM and T47D cells (0.756105 cells/ml) were treated with
MESB (0.1, 0.2, 0.5 and 1 mg/ml) and incubated for 48 and 72 h.
Cells were collected and subjected to MTT assay. Experiments
were repeated three independent times, each with duplicate
reactions and presented as bar diagram with error bars.
LDH Release Assay
Lactate dehydrogenase (LDH) assay was performed to assess the
LDH release into the media following MESB treatment (0.1, 0.2,
0.5 and 1 mg/ml) on both CEM and T47D cells after 48 and 72 h
of incubation as described earlier [23]. The cells were lysed using
0.1% Triton-X 100 in PBS. The amount of LDH released in both
culture media and cell lysate was measured at 490 nm using an
ELISA reader (BioRad, USA). The percentage of LDH release
was calculated as LDH release in media/(LDH release in media +
intracellular LDH release)6 100.
Western Blot Analysis
Cell lysate was prepared following treatment with MESB on
T47D cells (0, 0.1, 0.4, 0.7 mg/ml for 48 h) as described and used
for western blotting [24]. Western blotting experiments were
performed by using ,30 mg of protein. Samples were electro-
phoresed on 8-12% SDS-PAGE, proteins were transferred to
PVDF membrane (Millipore, USA) and probed with respective
primary and secondary antibodies. The primary antibodies against
MCL-1, BCL-xL, BAX, BID, p53, MDM2, p73, PARP1, SMAC/
DIABLO, CYTOCHROME C, APAF1, CASPASE 3 and
CASPASE 9 were used. Anti-TUBULIN and anti-ACTIN were
used as the loading control. The blots were developed using
chemiluminescent reagent (ImmobilonTM western, Millipore,
India) and scanned using gel documentation system (LAS 3000,
FUJI, JAPAN).
Western blotting studies were also performed using cytosolic
extracts prepared following treatment with MESB. T47D cells
were treated with MESB for 48 h (0, 0.1, 0.4, 0.7 mg/ml).
Cytosolic fractions were separated using mitochondrial extraction
kit (IMGENEX, Cat.No. 10082k), western blotting was performed
using anti-CYTOCHROME C and anti-SMAC/DIABLO.
Animals and Ethics Statement
Mice were maintained as per the principles and guidelines of the
ethical committee for animal care of Indian Institute of Science
(IISc) in accordance with Indian National Law on animal care and
use. The experimental design of the present study was approved by
Figure 2. Effect of MESB on progression of tumor in mice. Solid tumor was induced in Swiss albino mice by injecting breast adenocarcinoma
cells. Following tumor development, mice were orally treated with MESB (2 g/kg body weight) until 45th day. A. Effect of MESB on tumor progression
at different time points. Data shown is derived from three independent experiments containing 10 animals each. Error bars indicate standard
deviation. B. Kaplan-Meier survival curves of mice treated with MESB. C. The chemopreventive effect of MESB on EAC induced mice. The
experimental mice were orally fed with MESB for 20 days prior to the EAC injection and were compared with control group, which did not receive
pretreatment by MESB. D. Kaplan-Meier survival curves of mice pretreated with MESB.
doi:10.1371/journal.pone.0047021.g002
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Institutional animal ethics committee (Ref. CAF/Ethics/125/
2007/560), Indian Institute of Science, Bangalore, India.
Swiss albino mice, 6–8 weeks old weighing approximately 18–
22 g were purchased from central animal facility, Indian Institute
of Science, Bangalore, India and maintained in the animal house,
Department of Biochemistry, IISc. The animals were housed in
polypropylene cages and provided standard pellet diet (Agro
Corporation Pvt. Ltd., India) and water ad libitum. The standard
pellet diet composed of 21% protein, 5% lipids, 4% crude fiber,
8% ash, 1% calcium, 0.6% phosphorus, 3.4% glucose, 2% vitamin
and 55% nitrogen-free extract (carbohydrates). The mice were
maintained under controlled temperature and humidity with
a 12 h light/dark cycle.
Preparation of Breast Adenocarcinoma Cells
Ehrlich ascites carcinoma (EAC) is an undifferentiated carcino-
ma, originally hyperdiploid and has high transplantable capability,
rapid proliferation, shorter life span and 100% malignancy. EAC
resembles human tumors which are most sensitive to chemother-
apy due to the fact that they are undifferentiated and have a rapid
growth rate. A fixed number of viable breast adenocarcinoma cells
(16106 cells/22 g b. wt) were implanted into the peritoneal cavity
of each donor mouse and allowed to multiply. The tumor cells
were withdrawn, diluted in saline, counted and re-injected (16106
cells/animal) to the right thigh of experimental animal for
development of solid tumor as described [25].
Evaluation of Antitumor Activity of MESB in Mouse
In each experiment, out of 30 Swiss albino mice, 20 were
injected with Ehrlich ascites carcinoma cells for developing the
solid tumor. Group 1 served as untreated (normal) control (n = 10).
EAC injected animals were divided into 2 groups of 10 animals
each. Group 2 was considered as tumor control and received no
treatment. Group 3 received oral feeding of 2 g/kg of MESB
dissolved in water after 12 days of tumor development and
continued up to 45 days. The experiment was repeated 3
independent times.
Size of the developing tumor was measured in both group 2 and
3 animals by using vernier callipers on alternative days for the
entire life span of the animals. Tumor volume was calculated using
the formula V= 0.5ab2, where ‘a’ and ‘b’ indicates the major and
minor diameter, respectively [25,26]. At the end of 30th and 45th
Figure 3. Gross appearance of mice and its organs following MESB treatment. Gross appearance of mice and its selected organs following
treatment with MESB on tumor bearing mice after 30th (A) and 45th (B) days of tumor development.
doi:10.1371/journal.pone.0047021.g003
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day of experimental period, one animal from each group [normal
(group 1), tumor (group 2) and MESB treated tumor animals
(group 3)] was sacrificed by cervical dislocation, tissues were
collected and stored under appropriate conditions. Each experi-
ment was repeated three independent times.
The percentage of increase in lifespan was calculated and
compared with control animals. The death pattern for control
animals and MESB treated animals was recorded and % increase
in lifespan was calculated using the formula [(T-C)/C] x100,
where ‘T’ indicates the number of days the MESB treated animals
survived and ‘C’ indicates the number of days tumor animals
survived [25,27].
The Chemopreventive Effect of MESB
For each experiment, out of 10 animals, 5 (group 1) were orally
fed with MESB (2 g/kg b.wt) for 20 days prior to the EAC
injection and treatment was continued up to 45 days. Group 2
animals were considered as tumor control with no MESB
treatment. The tumor volumes were measured after 12 days of
EAC injection in both group 1 and group 2 animals. Each
experiment was repeated two independent times. The percentage
of increase in lifespan was calculated and compared with control
animals.
Histological Evaluation
Tumor and liver tissues of normal and experimental mice were
collected and processed as per standard protocol. Briefly, the
tissues were embedded in paraffin wax, sectioned at 5–10 mm in
rotary microtome (Leica Biosystems, Germany) and stained with
hematoxylin and eosin [25,28]. Each section was evaluated by
light microscopy and images were captured (Carl Zeiss, Germany).
Evaluation of Side Effects in Normal Animals
Swiss albino mice were fed with MESB (2 g/ml) for ten days to
assess the side effects. Control and treated groups consisted of 8
mice each. Body weight was measured on every alternate day and
the average body weight was plotted. To evaluate the effect of
MESB on physiological functions, blood was collected after ten
days of MESB treatment and analysed as described earlier [25].
Serum was separated from the blood and used for liver and kidney
function tests by comparing the levels of alkaline phosphatase
(ALP), creatinine and urea. The blood count was performed by
scoring the number of RBC and WBC in whole blood as described
earlier [25]. Values obtained were presented as mean6SEM.
Immunohistochemical (IHC) Analysis
Immunohistochemical staining was performed on formalin
fixed, paraffin embedded tissues, which were sectioned at
a thickness of 5 mm. Slides were de-paraffinized using xylene,
Figure 4. Histopathology of the tumor tissues and liver of mice following MESB treatment. Histopathalogical sections of thigh and liver
of a tumor bearing mouse with and without treatment with MESB after 30th day A(a–f) and C(a–f) and 45th day B(a–f) and D(a–f) of development of
tumor. Magnification shown are 10x (a, c and e in all panels) and 40x (b, d and f in all panels).
doi:10.1371/journal.pone.0047021.g004
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rehydrated and treated with 3% H2O2 in PBS and IHC staining
was performed as described earlier [29,30]. In brief, antigen
retrieval was done using 0.01 M sodium-citrate buffer (pH 6.0)
followed by blocking in PBST containing 0.1% BSA. Primary
antibody incubation (Ki67, t-BID or p53BP1; 1:100) was carried
out overnight at 4uC. Slides were washed and incubated with
biotinylated secondary antibody (1 h, RT, 1:200) followed by
streptavidin-HRP (1:1000). Slides were washed (PBS containing
0.1% Tween 20), colour was developed using DAB+H2O2,
counterstained with haematoxylin and mounted in DPX (Sigma-
Aldrich, USA). Images were captured using light microscope (Carl
Zeiss, Germany).
Statistical Analysis
Values are expressed as mean 6 SEM for control and
experimental samples and statistical analysis was performed using
one-way ANOVA followed by Dunnett’s test. For this analysis,
Graphpad software prism 5.1 was used. The values were
considered as statistically significant, if the p-value was equal to
or less than 0.05.
Results
MESB causes a Time-dependent Cytotoxicity of CEM and
T47D Cell Lines
We have evaluated the cytotoxic effect of MESB on human
breast cancer (T47D) and leukemia (CEM) cells using trypan blue
dye exclusion and MTT assays. Results showed a dose-dependent
effect on cell viability of CEM upon treatment with increasing
concentrations of MESB (Fig. 1A). Comparable results were also
obtained when MTT assay was used to determine the effect of
MESB on proliferation of CEM cells (Fig. 1B). The treatment of
MESB on T47D cell lines also resulted in detectable reduction in
cell viability, particularly at 72 h (Fig. 1D). A similar result was
obtained when effect of MESB on cell proliferation was analysed
by MTT assay (Fig. 1E). Thus, our results suggest that extracts
prepared from strawberry were capable of inducing cytotoxicity in
two different cancer cell lines of hematopoietic (leukemia) and
epithelial origin (breast cancer).
LDH assay was used to determine the cellular integrity
following MESB treatment (0.1, 0.2, 0.5 and 1 mg/ml). Results
Figure 5. Evaluation of side effects of MESB in mice. Mice were orally fed with MESB (2 g/kg. b. wt) for 10 days. A. Data showing average body
weight changes in the control (n = 8) and MESB treated mice (n = 8). In all the cases, error bars are indicated. B. Hematological and serum profile of
mice following oral feeding with MESB at day 10 (n = 8 for both control and treated). Values are indicated in mean 6 SEM.
doi:10.1371/journal.pone.0047021.g005
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showed a concentration and time-dependent increase in the LDH
release upon treatment with MESB in both CEM and T47D cell
lines (Fig. 1C and 1F).
MESB Treatment Prevents the Progression of Breast
Adenocarcinoma in Mice and Results in Increased Life
Span
Breast adenocarcinoma cells were used for generating solid
tumor in Swiss albino mice. Upon treatment with MESB (from
12th day of tumor development on every alternate day until 45th
day, 2 g/kg), a significant reduction in the tumor volume was
observed compared to untreated control animals bearing tumor
(Fig. 2A, 3A). By 45th day of treatment, most of the MESB treated
animals showed no tumor, unlike untreated tumor animals (Fig. 2A
and Fig. 3B). More importantly, we observed a significant increase
in the lifespan of MESB treated animals (Fig. 2B).
When chemopreventive effect of MESB was studied on tumors
induced by breast adenocarcinoma cells, following oral feeding of
MESB for 20 days prior to injection of tumor inducing cells, results
showed a significant reduction in solid tumor formation as
Figure 6. Immunostaining studies for apoptotic and DNA damage markers following treatment of mice bearing tumors with MESB.
A-D. Ki67, p53BP1, BID and t-BID immunostaining of untreated (a, b) and treated (c, d) tumor tissues (30th day of treatment). Antibodies used were
Ki67 (A) p53BP1 (B), BID (C) and t-BID (D).
doi:10.1371/journal.pone.0047021.g006
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compared to controls (Fig. 2C). Further, we observed a significant
increase in the life span of MESB pretreated animals as compared
to control group of animals (Fig. 2D). These results indicate that
strawberry extracts can provide significant chemoprevention in
mice.
Gross anatomical appearance of thigh tissue containing tumor,
liver and spleen of control and experimental animals on 30th and
45th day after tumor development further confirmed the effect of
MESB in regression of tumor (Fig. 3A, B). The appearance of the
treated animals after 45 days as well as morphology of their
dissected organs were comparable with those of normal animals
indicating that MESB treatment did not lead to visible alterations
(Fig. 3).
Histopathological studies were performed on sections from
thigh or thigh bearing tumor and liver tissues of normal, tumor
bearing and MESB treated animals after 30th and 45th days of
treatment using haematoxylin-eosin staining (Fig. 4). Thigh tissue
from tumor bearing mouse showed damages in muscle architec-
ture and tumor cell proliferation with very high nuclear staining
[Fig. 4A(a–d), B(a–d)]. After treatment with MESB, damages in
muscle architecture and tumor cell proliferation were limited
indicating the reduction in tumor growth [Fig. 4A(e, f), B(e, f)].
The adverse effect of MESB treatment on other tissues was
analysed by taking liver as a model organ. Studies using
hematoxylin and eosin stained liver sections showed infiltration
of inflammatory cells in animals bearing tumors compared to no
tumor controls [Fig. 4C(a-d), D(a–d)]. However, upon treatment
with MESB, the liver exhibited mostly normal morphology, with
no or limited infiltration in hepatocytes [Fig. 4C(e,f), D(e,f)].
Therefore, the above results suggest that treatment with straw-
berry fruit crude extracts did not adversely affect the morphology,
anatomy or physiology of the other organs.
In order to evaluate side effects of MESB, normal mice were fed
with MESB for 10 days and results showed similar levels of serum
profile (alkaline phosphatase, creatinine and urea) compared to
untreated controls (Fig. 5B). Further there was no significant
difference in RBC and WBC counts in MESB treated mice
compared to the controls (Fig. 5B). Besides, there was no
significant change in body weight measured after 10 days of
MESB treatment (Fig. 5A).
Effect of MESB Treatment on the Expression of Ki67,
p53BP1, BID and t-BID in Tumor Tissues
Ki67 is a cell proliferation marker for tumor progression [31].
Immunohistochemical staining of Ki67 protein tumor section
showed increased cell proliferation in untreated animals bearing
Figure 7. Expression of apoptotic proteins in T47D cells following MESB treatment. Whole cell extracts (A-C) and cyotosolic extracts (D)
were prepared from T47D cells following treatment with MESB (0, 0.1, 0.4, 0.7 mg/ml for 48 h). Western blotting studies were performed using
primary antibodies against (A) MCL-1, BCL-xL, BAX and BID, (B) p53, MDM2, p73 and PARP1, (C) SMAC/DIABLO, CYTOCHROME C, APAF1, CASPASE 3
and CASPASE 9, (D) SMAC/DIABLO and CYTOCHROME C. In panels A-C, TUBULIN was used as an internal loading control, while in D, ACTIN was used.
doi:10.1371/journal.pone.0047021.g007
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tumor, while it decreased upon treatment with MESB (Fig. 6A).
An enhanced expression of p53 binding protein 1(p53BP1), a DNA
damage sensor, was observed upon treatment with MESB (Fig. 6B).
We have also observed activation of proapoptotic proteins, BID
and t-BID following treatment with MESB compared to untreated
tumor tissues (Fig. 6C and D) suggesting the induction of apoptosis
in tumor cells in mice. Therefore, our results suggest that MESB
treatment inhibits the proliferation of tumor cells by activating
apoptosis in mice bearing breast adenocarcinoma allograft.
MESB Activates Intrinsic Pathway of Apoptosis in Breast
Cancer Cells
In order to understand the mechanism by which MESB induces
cell death, we chose the breast cancer cell line, T47D, for further
investigation. T47D cells were treated with increasing concentra-
tions of MESB, cell extracts were prepared and used for
immunoblotting analysis. Results showed activation of apoptotic
marker, MCL-1, which acts as a proapoptotic protein upon
cleavage. We find that MESB treatment resulted in prominent
cleavage of MCL-1 as compared to the control (Fig. 7A). MESB
treatment also resulted in downregulation of BCL-xL, an
antiapoptotic protein, at the highest concentration studied
(Fig. 7A). Results also showed a significant upregulation of
expression of proapoptotic proteins such as BAX and BID
(Fig. 7A).
Previously, it has been shown that the tumor suppressor gene,
p53, is mutated in T47D cells [32,33]. Consistent to this, we could
not find any significant change in p53 expression in this cell line,
even upon addition of MESB (Fig. 7B). MDM2 is a modulator of
p53 and we observed no considerable difference in its expression
when treated with MESB (Fig. 7B). Interestingly in case of p73,
a paralogue of p53, we observed a dose-dependent increase in
expression (Fig. 7B and 8).
p73 can induce apoptosis through both intrinsic as well as
extrinsic pathways [34]. Results showed a low level of PARP
cleavage and activation of CASPASE 3 and CASPASE 9
indicating the activation of intrinsic pathway of apoptosis
(Fig. 7B, C). A significant increase in the expression of SMAC/
DIABLO, CYTOCHROME C and APAF1 upon treatment with
MESB as compared to control, also confirmed activation of the
intrinsic pathway of apoptosis (Fig. 7C). More importantly,
western blotting using cytosolic fractions of MESB treated T47D
cells, showed release of CYTOCROME C into the cytosol
(Fig. 7D). However, the expression of SMAC/DIABLO did not
change significantly (Fig. 7D). Thus, our results suggest that
extracts prepared from strawberry fruits induce intrinsic pathway
of apoptosis in breast cancer cells (Fig. 8).
Discussion
The correlation between higher intake of fruits, vegetables and
decreased risk of developing certain cancers attributes to the
content of antioxidants and other secondary metabolites present in
plants. In the current study, we have evaluated the anticancer
property of crude extract of strawberry fruits. Our studies using
two cell lines of different origin suggest that irrespective of the
cancer type, MESB could induce cytotoxicity, as shown by three
independent assaying methods. We have used a mice model
bearing breast adenocarcinoma to evaluate the chemotherapeutic
and chemopreventive potential of strawberry. Besides, we have
also identified the mechanism by which the strawberry extracts
induce apoptosis in cancer cells.
Previously, it has been reported that strawberry extracts induce
cytotoxicity in microgram range [3] whereas, in the present study
it was in milligram range. This difference could be attributed to
the enrichment of polyphenolic compounds by the removal of free
sugars, organic acids, vitamin C etc [3]. Moreover, when enriched
polyphenolic compounds were used, normal cells also showed
Figure 8. Proposed model for mechanism of MESB induced cytotoxicity. MESB treatment resulted in activation of intrinsic pathway of
apoptosis. This is mediated through activation of p73. This activation leads to changes in the level of mitochondrial apoptotic protein, BAX. This may
result in the imbalance of proapoptotic/antiapoptotic proteins. The activation of BAX, further leads to cleavage of MCL-1 and release of
CYTOCHROME C, which along with APAF1 helps in cleavage of CASPASE 9. Cleaved CASPASE 9 activates CASPASE 3 which further initiates PARP1
cleavage and cell death.
doi:10.1371/journal.pone.0047021.g008
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equal sensitivity as cancer cells. In contrast, when methanolic
extracts of strawberry were used, we did not observe any toxic
effect in normal tissues or side effects in normal mice. This suggests
that removal of certain components from strawberry extracts,
could affect its specificity, resulting in toxicity to even normal cells.
p53 is a widely studied tumor suppressor gene. In response to
DNA damage, p53 can act as a negative regulator for cell survival.
It has been shown that most of the tumor malignancies are
associated with mutation or allelic loss of p53 gene. In contrast,
p73, a protein of p53 family, which shares significant structural
and functional similarity with p53 protein, is rarely mutated in
cancers [19]. Previously, it has also been reported that p73
isoforms can interact and activate the p53 responsive genes, and
can regulate the cell survival or cell death [35]. Therefore, one of
the important strategies to induce apoptosis in tumor cells could be
by using molecules or extracts that can help in upregulation of p73
[36]. Interestingly in our study, we do find a concentration
dependent increase in the expression of p73 upon addition of
strawberry extracts in T47D cells, in which p53 function is
abrogated. Consistent to this, we observed a dose dependent
increase in both p73 and BAX. The increased expression of BAX
can result in its penetration to mitochondrial outer membrane
leading to release of CYTOCHROME C, thereby activating
CASPASE 9 (Fig. 8). Western blot analysis following treatment
with MESB indeed confirmed such a hypothesis. Expression of
SMAC/DIABLO, a mitochondrial protein that can abolish the
inhibitory activity of IAP (inhibitor of apoptotic proteins), also
showed a consistent upregulation, upon MESB treatment [37].
APAF1, one of the members of apoptosome, also showed elevated
expression, consistent with the release of CYTOCHROME C.
Hence, the above results in conjunction with activation of
CASPASE 9, CASPASE 3 and PARP1 demonstrated activation
of intrinsic pathway of apoptosis by MESB to induce cell death.
These results suggest that activation of p73, when p53 is mutated,
is a good strategy to induce apoptosis in cancer cells. Previously,
studies using polyphenolic rich Aronia melanocarpa juice also showed
activation of p73 in p53 null cells [38]. Besides, it has been shown
that polyphenols isolated from red vines, known as gallic acid can
inhibit the induction and progression of colon cancer in mice
models [39]. Apart from this, p73 associated induction of apoptosis
was also reported in jurkat cell line, when treated with red vine
polyphenols [40]. However, all these studies had only limited
scope, as they did not assess their effect on normal cells, unlike the
present study.
MESB treatment on mice bearing tumor resulted in significant
reduction in tumor volume without affecting the function of other
organs along with approximately 4-fold increase in the lifespan.
The histological evaluation showed that morphology and cellular
architecture of the tissues was unaffected by the MESB treatment.
Immunohistochemical studies also confirmed a decrease in cell
proliferation as well as activation of apoptosis following treatment
with MESB, suggesting regression of tumor in mice models. The
observed protection from tumorigenesis upon pretreatment with
strawberry extracts emphasizes the importance of strawberry
fruits. Although the mechanism by which it exerts the chemopre-
vention is not clear, it reveals the added value of intake of
strawberry fruits. Thus, the present study emphasizes the high
therapeutic potential of strawberry. Further, our studies revealed
that it can modulate the expression of p73, when p53 is mutated in
cancers like breast cancer and can activate the mitochondrial
pathway of apoptosis to abrogate cancer cell proliferation. Thus,
our study clearly shows that strawberry can act as a good dietary,
chemopreventive as well as therapeutic agent.
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